| HealthPartners | Oncology - datopotamab deruxtecan-dlnk (Datroway®) | 2026-04-01 |
| HealthPartners | Oncology - emapalumab-lzsg (Gamifant®) | 2026-04-01 |
| HealthPartners | Oncology - fam-trastuzumab deruxtecan-nxki | 2026-04-01 |
| HealthPartners | Oncology - inotuzumab ozogamicin (Besponsa™) – | 2026-04-01 |
| HealthPartners | Oncology - polatuzumab vedotin-piiq (Polivy™) – | 2026-04-01 |
| HealthPartners | Oncology - tagraxofusp-erzs (Elzonris™) | 2026-04-01 |
| HealthPartners | Oncology - tagraxofusp-erzs (Elzonris™) – Minnesota | 2026-04-01 |
| HealthPartners | Oncology - talimogene laherparepvec (Imlygic®) – | 2026-04-01 |
| HealthPartners | Oncology - trabectedin (Yondelis®) – Minnesota | 2026-04-01 |
| HealthPartners | Oncology testing: cancer screening and surveillance | 2026-04-01 |